These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 435634)

  • 1. Interference of levamisole with inhibition of E-rosette formation by Hodgkin's disease and systemic lupus erythematosus cytotoxic sera.
    Del Giacco GS; Tognella S; Leone AL; Locci F; Cornaglia P; Sangiuolo A; Grifoni V
    Blood; 1979 May; 53(5):1002-6. PubMed ID: 435634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B; Biniaminov M; Shoham C; Rosenthal E
    N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of levamisole on E-rosette forming cells and serum adenosine deaminase in Hodgkin's disease.
    Di Perri T; Auteri A; Laghi Pasini F; Mattioli F; Volpi L
    J Immunopharmacol; 1979; 1(2):233-46. PubMed ID: 553110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease].
    Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):255-61. PubMed ID: 1087885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-surface modifications of normal human peripheral lymphocytes induced by lymphocytotoxic sera of patients with systemic lupus erythematosus and Hodgkin's disease, studied by scanning electron microscopy.
    Del Giacco GS; Riva A; Loy M; Batzella MG; Cengiarotti L; Leone AL; Locci F; Murru V
    Haematologica; 1979 Apr; 64(2):148-58. PubMed ID: 112006
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levamisole and its effect on the E-rosette restoration test in healthy subjects and in systemic lupus erythematosus (author's transl)].
    Rovenský J; Pekárek J; Holt PJ; Mistina T; Zitnan D
    Cas Lek Cesk; 1981 Jun; 120(25):761-3. PubMed ID: 7260993
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of advanced Hodgkin's disease in remission.
    Klener P; Hausner P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of T gamma rosette formation by the sera from patients with systemic lupus erythematosus. Relation to T gamma-specific antilymphocyte antibody.
    Okudaira K; Tanimoto K
    Int Arch Allergy Appl Immunol; 1983; 71(4):346-51. PubMed ID: 6602775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
    Modai D; Peller S; Weissgarten J; Shaked U; Kaufman S
    Isr J Med Sci; 1981 Dec; 17(12):1115-8. PubMed ID: 7327910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK; Gupta RK; Sadana JR
    Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of levamisole on E rosette inhibition by serum of malnourished children.
    Salimonu LS
    Biomed Pharmacother; 1983; 37(6):276-80. PubMed ID: 6200157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.